Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Effective treatment of depression in patients having impaired learning and/or memory or certain EEG characteristics with a benzylpiperazine-aminopyridine agent

Effective treatment of depression in patients having impaired learning and/or memory or certain EEG characteristics with a benzylpiperazine-aminopyridine agent

US Patent 12233059 · Granted Feb 25, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of depression using machine learning2025
Compositions and methods for the treatment of depression2025
Treatment of depression using machine learning2025
Treatment of depression using machine learning2025
Method of treatment and selection of patients benefiting from agomelatine based 2025
Method of treatment and selection of patients benefiting from agomelatine based 2025
Method of treatment and selection of patients benefiting from agomelatine based 2025
Method of treatment and selection of patients benefiting from agomelatine based 2025
Effective treatment of depression in patients having impaired learning and/or me2025
Effective treatment of depression in patients having impaired learning and/or me2025
Effective treatment of depression in patients having impaired learning and/or me2025
Effective treatment of depression in patients having impaired learning and/or me2025